Dare Bioscience Inc (DARE)
0.4498
+0.01
(+3.31%)
USD |
NASDAQ |
Jun 14, 16:00
0.4272
-0.02
(-5.02%)
After-Hours: 20:00
Dare Bioscience Cash from Investing (TTM): -0.6367M for March 31, 2024
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
Date | Value |
---|---|
March 31, 2024 | -0.6367M |
December 31, 2023 | -0.6294M |
September 30, 2023 | -0.0248M |
June 30, 2023 | -0.0577M |
March 31, 2023 | -0.0585M |
December 31, 2022 | -0.0631M |
September 30, 2022 | -0.0604M |
June 30, 2022 | -0.0199M |
March 31, 2022 | -0.0191M |
December 31, 2021 | -0.0145M |
September 30, 2021 | -0.0169M |
June 30, 2021 | -0.0024M |
March 31, 2021 | -0.0176M |
December 31, 2020 | |
September 30, 2020 | |
June 30, 2020 | |
March 31, 2020 | |
December 31, 2019 | |
September 30, 2019 | |
June 30, 2019 | |
March 31, 2019 |
Date | Value |
---|---|
December 31, 2018 | |
September 30, 2018 | |
June 30, 2018 | |
March 31, 2018 | |
December 31, 2017 | |
September 30, 2017 | |
June 30, 2017 | |
March 31, 2017 | |
December 31, 2016 | 0.00 |
September 30, 2016 | -0.113M |
June 30, 2016 | -0.502M |
March 31, 2016 | -0.697M |
December 31, 2015 | -0.484M |
September 30, 2015 | -0.48M |
June 30, 2015 | -0.524M |
March 31, 2015 | -0.21M |
December 31, 2014 | -0.185M |
September 30, 2014 | -0.076M |
June 30, 2014 | 0.00 |
March 31, 2014 | -0.009M |
December 31, 2013 | -0.007M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-0.6367M
Minimum
Mar 2024
-0.0024M
Maximum
Jun 2021
-0.1247M
Average
-0.0248M
Median
Sep 2023
Cash from Investing (TTM) Benchmarks
Altimmune Inc | -39.09M |
Verastem Inc | -12.66M |
Oragenics Inc | -- |
Actinium Pharmaceuticals Inc | -0.088M |
Orgenesis Inc | -2.468M |